Pathology
CD8 T-Cell–Predominant Lymphocytic Esophagitis Associated with GERD
In patients with reflux esophagitis (RE), increased lymphocytes are often part of a mixed inflammatory infiltrate that also includes eosinophils and/or neutrophils. Less frequently, lymphocytes are the only type of inflammatory cells associated with gastroesophageal reflux disease (GERD). More...05 Oct 2021
Next Generation Rapid Antibiotic Susceptibility Testing (AST) Platform Granted FDA Breakthrough Device Designation
Selux Diagnostics, Inc.’s (Boston, MA, USA) Next Generation Phenotyping (NGP) platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for positive blood culture and sterile body fluid samples. More...05 Oct 2021
Gut Bacteria Are Possible Indicators of Colon Cancer Risk
Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and fatigue. More...28 Sep 2021
Heparin-Binding Protein Levels Dramatically Increase in Acute Pancreatitis
Heparin-binding protein (HBP), also known as CAP37 and azurocidin, is a glycoprotein stored in azurophilic granules and secretory vesicles in neutrophils that is released upon neutrophil activation early in the systemic inflammatory response. More...25 Sep 2021
Urinary VEGFA and Renal Pathology Evaluated for IgA Nephropathy Patients
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common primary glomerulonephritis and is the leading cause of end-stage renal disease (ESRD) in China. Renal biopsy remains the golden standard for diagnosing and monitoring IgA nephropathy (IgAN). More...25 Sep 2021
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
CerTest Biotec (Zaragoza, Spain; www.certest.es) has joined the fight against multidrug resistant strains (MDR) bacterial infections by developing real-time PCR assays for the fast detection of genes or punctual mutations that confer resistance to antibiotics from both Gram-positive and Gram-negative pathogens. More...23 Sep 2021
Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
In Other News
Blood Testing Distinguishes Benign Tumors from Precancerous Condition
CCN1 Analyzed as a Biomarker for Breast Cancer Detection
Liquid Biopsy Assay Evaluated for Early Detection of Gastric Cancer
PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC
World's First AI-Powered Solution for Gastrointestinal Cancer Diagnostics to Help Pathologists Reduce Turnaround Time
NanoVelcro Cell Technology Applied in Diagnosis of Pregnancy Complications
Exhaled Nitric Oxide and Eosinophil Count Diagnose Eosinophilic Asthma
Leptomeningeal Disease Diagnosed Using CSF Cell-Free DNA
Biomarker p-120 Catenin Distinguishes Conventional Urothelial Carcinoma from Variants
Novel Blood-Based Test Bolsters MRI-Based Prostate Cancer Screening
Key Factors Signal Infection Risk in Alcoholic Hepatitis
Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes
Multitarget Fecal Immunochemical Test Validated for Colorectal Cancer
CSF Conversion Assay Identifies Lewy Body Disease Cognitive Impairment
Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes
Diagnostic Biomarker MMP-13 Explored for Cutaneous Squamous Cell Carcinoma
Immunoassays Compared for Serum HE4 Estimation for Ovarian Cancer
Preemies' Blood Type Tied to Risk for Necrotizing Enterocolitis
Telomerase Reverse Transcriptase Protein Expression Evaluated for Melanomas
Electronic Nose Sensor Accurately Detects Ovarian, Pancreatic Cancers
Protein Biomarker Helps Diagnose Pancreatic Cancer
Biomarkers Diagnose and Predict Acute Pancreatitis
Respiratory Syncytial Virus Bronchiolitis Has Different Subtypes
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.